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AbstrAct
Background Cancer survival in the UK has doubled in 
the last 40 years; however, 1-year and 5-year survival 
rates are still lower than other countries. One cause 
may be a delay between referral into secondary care 
and subsequent investigation. We set out to evaluate the 
impact of a straight to test pathway (STTP) on time to 
diagnosis for upper gastrointestinal (UGI) cancer.
Methods Six hospital Trusts across the East Midlands 
Clinical Network introduced a STTP enabling general 
practitioners to refer patients with suspected UGI cancer 
(oesophageal/gastric) for immediate investigation, without 
the need to see a hospital specialist first. Data were 
collected for all patients referred between 2013 and 
2015 with suspected UGI cancer and stratified by STTP or 
traditional referral pathway. Overall time from referral to 
diagnosis was compared. Data from two Trusts who did 
not implement STTP acted as control.
Results 340 patients followed the STTP pathway and 
495 followed the traditional route. STTP saved a mean of 
7 days from referral to treatment (with a 95% CI of 3 to 
11 days, p<0.008) and a mean of 16 days from referral 
to diagnosis, when compared with a traditional referral 
pathway. The number of diagnostic tests performed using 
STTP or traditional referral pathways were similar.
Conclusion A STTP is associated with an overall reduction 
of 1 week from referral to treatment for UGI cancer. The 
approach is feasible and did not require more resource. 
Larger studies are required to assess whether this time 
saving translates into improved cancer outcomes.
InTroducTIon
The UK has a significant burden of upper 
gastrointestinal (UGI) cancer (comprising 
oesophageal and gastric cancer) and poor 
survival figures. In 2013, the UK was the third 
worst performing nation in the world for 
oesophageal cancer with 12.74 deaths per 
100 000 population.1 Patients with UGI cancer 
have a poor prognosis compared with other 
cancers, and in England, UGI cancers have 
the fourth (for males) and fifth (for females) 
lowest 1-year survival rate of all cancers.2
Within England, the East Midlands is one 
of worst performing regions for UGI cancer. 
In the East Midlands between 1990 and 2013, 
the annual percentage change in oesophageal 
cancer deaths per 100 000 people was a 1.16% 
increase, compared with 1.08% increase in 
Yorkshire & Humber and a 0.81% decrease in 
the Greater London region. There were 607 
new cases of oesophageal cancer in the East 
Midlands in 2014 and 423 new cases of gastric 
cancer.3 In 2014, 521 patients died of oesoph-
ageal cancer and 289 patients died of gastric 
cancer in the East Midlands.4 
The crude incidence rate (per 100 000 
people) for oesophageal cancer in the East 
Midlands in 2014 was 19.95 diagnoses iden-
tified per 100 000 people for males and 9.85 
for females. The crude incidence rates for 
gastric cancer were 14.01 and 6.76 for males 
and females, respectively.5 The East Midlands 
region had the highest crude rate (per 
100 000 people) of gastric cancer for males 
over 65 years old in England in 2013.5
There is evidence that early detection of 
cancer can increase the chances for successful 
treatment.6 In order to identify potential 
delays in the care pathway, The International 
Cancer Benchmarking Partnership (ICBP) 
study explored differences in how general 
practitioners (GPs) manage patients with 
symptoms. GPs in England, Northern Ireland 
and Wales consistently reported a lower 
readiness to refer or investigate patients 
with potential cancer symptoms compared 
with Australia, Canada, Sweden, Norway and 
Denmark. The results suggested that differ-
ences in how GPs access diagnostic tests and 
interact with different services within the 
local health economy may impact on patient 
management.7
In an attempt to improve access to cancer 
care and reduce cancer related mortality, NHS 
England (supported by Cancer Research UK 
and Macmillan Cancer Support) set up the 
ACE Programme (Accelerate, Coordinate, 
Evaluate). ACE focuses on addressing system 
delays identified by available research and 
includes the development and evaluation of 
new streamlined diagnostic pathways.
 o
n
 10 August 2018 by guest. Protected by copyright.
http://bmjopenquality.bmj.com/
BM
J O
pen Qual: first published as 10.1136/bmjoq-2018-000328 on 21 July 2018. Downloaded from 
2 Jones JA, et al. BMJ Open Quality 2018;7:e000328. doi:10.1136/bmjoq-2018-000328
Open access 
As part of the ACE programme, the East Midlands Clin-
ical Cancer Network focused on UGI cancer. Hospital 
Trusts in the region introduced the ‘Straight To Test 
Pathway’ (STTP) whereby GPs are able to refer patients 
with suspected UGI cancer directly for a diagnostic test 
(oesophagogastroduodenoscopy), bypassing the tradi-
tional initial hospital outpatient appointment.
The STT approach is reliant on high-quality GP refer-
rals, based on the use of clinical decision support tools 
that facilitate appropriate referral of patients onto the 
UGI diagnostic pathway. This requires strong collabora-
tion across the primary and secondary interface to agree 
the appropriate referral criteria aligned to the NICE 2015 
guidance (NG12), educate GPs in how to understand and 
apply the criteria and use any required technology such 
as electronic referral and booking systems to streamline 
the referral processes.8
We set out to establish the impact of the upper GI STTP 
in the East Midlands.
MeThods
STTP was introduced in Derby Hospitals Foundation 
Trust, Nottingham University Hospitals and University 
Hospitals of Leicester Trust following the release of the 
‘Direct access to diagnostic tests for cancer: best practice 
referral pathways for general practitioners’ document by 
the Department of Health in April 2012.9
Data were captured for patients referred between 
01/01/2013 and 31/12/2015 with suspected upper GI 
cancer, that went on to be diagnosed with cancer for each 
Trust in this evaluation. Data items captured were:
 ► Referral received date: the date on which a decision 
was made to refer the patient to Secondary Care with 
suspected cancer.
 ► First seen date: the date where the patient saw an 
appropriate specialist for cancer care. This was 
defined as either: (1) the first outpatient appointment 
with an appropriate cancer specialist or (2) the first 
diagnostic procedure. The first diagnostic date was 
defined as the first imaging or radio-diagnostic event 
date or clinical intervention date.
Whichever of (1) and (2) occurred first was coded.
 ► Clinical diagnosis date: either the date the cancer 
was confirmed or the diagnosis was agreed. This was 
normally the date of the authorised Pathology Labo-
ratory Service Report confirming the cancer or the 
date of the Multidisciplinary Team Meeting.
 ► Treatment start date: the date of the first cancer treat-
ment. If the cancer treatment modality was coded as 
surgery, the treatment start date for cancer was the 
start date of the related surgical admission.10
Data were captured using each Trust’s individual cancer 
information systems (Infoflex and Somerset Cancer 
Registry). Data were captured on STTP patients and 
patients that followed the traditional pathway (ie, 
attended an outpatient appointment as their initial 
secondary care contact before investigation) to compare 
cohorts. Data were aggregated on an East Midlands wide 
level.
STTP was instituted at a primary care level, so Trusts 
could receive patients on both pathways (ie, STTP and 
traditional). Primary care providers referring into United 
Lincolnshire Hospitals and Northampton General 
Hospital did not implement STTP at the time; these 
Trusts data were captured and aggregated together to 
form a control cohort.
Analysis was performed comparing STTP against tradi-
tional pathway and control patients, measuring mean 
days between:
 ► Date of receipt of referral to date the patient was first 
seen in secondary care.
 ► Date of receipt of referral to date of clinical diagnosis.
 ► Date of clinical diagnosis to the date the decision to 
treat was made.
 ► Date of receipt of referral to date the decision to treat 
was made.
resulTs
Table 1 shows the number of referrals broken down by 
Trust, pathway and gender.
There was significant reduction in referral to treat-
ment time between patients on the STTP and traditional 
pathway. The traditional pathway times were similar to 
those in the control group (see table 2).
Figure 1 shows the distribution of patients on the pathway 
by the number of days between referral and diagnosis. There 
is a spike in the STTP line early on in the days from referral 
to diagnosis (groups of 10 days) axis with 55% of patients 
referred via STTP being diagnosed within 10–20 days. The 
Table 1 Number of referrals by Trust, pathway and gender
Pathway/Trust Female Male Unknown Total
STTP 126 214 340
Derby Hospitals 
Foundation Trust
32 50 82
Nottingham University 
Hospital
59 108 167
University Hospitals of 
Leicester Trust
35 56 91
Traditional 198 297 495
Derby Hospitals 
Foundation Trust
58 89 147
Nottingham University 
Hospital
117 164 281
University Hospitals of 
Leicester Trust
23 44 67
Control 201 356 9 566
Northampton General 
Hospital
127 222 9 358
United Lincolnshire 
Hospitals
74 134 208
STTP, straight to test pathway. 
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traditional pathway line is more evenly distributed with the 
peak being 29% being diagnosed within 20–30 days.
The STTP was associated with a longer time between 
diagnosis and treatment, negating some of the impact 
of the faster initial diagnosis. Table 2 shows the mean 
average number of days between diagnosis and treatment 
and suggests that traditional pathway patients waited a 
shorter amount of time between the diagnoses to treat-
ment period compared with patients on the STTP.
In figure 2, each line represents the number of patients 
on the pathway against the number of days between referral 
and treatment. There is a slight spike in the STTP line early 
on with 19% of patients referred via STTP being treated 
within 20–30 days of referral. The traditional pathway line 
is slightly more evenly distributed with the peak being 19% 
being treated within 40–50 days.
nuMber of requesTed endoscopIes
To establish the effect of STTP on the number of endosco-
pies requested, the total number of endoscopies performed 
in Trusts in the East Midlands for the same time frame as 
the data used in this evaluation was captured and is shown 
in table 3. These data show that the number of endoscopies 
performed overall in the region did not increase during the 
evaluation timeframe.
conclusIon
The UK has seen an improvement in cancer survival rates. 
However the outlook for UGI cancers is still poor; the 
age-standardised 1-year net survival (%) for men (aged 
15–99 years) between 2011 and 2015 was 46% and 47% 
for oesophageal and stomach cancers, respectively2; figures 
are similar for women and both cancers are in the bottom 
tertile in England for survival. There is evidence to suggest 
that poor survival data may relate to differences in access 
and availability for common diagnostic tests, in particular 
UGI endoscopy.
Against this background, and in order to try and reduce 
time between initial presentation and diagnostic imaging, 
we introduced and assessed a STTP for UGI cancer in the 
East Midlands. This was an ambitious and pragmatic project 
that used both Clinical Networks and the East Midlands 
Academic Health Sciences Network. The initial results 
are impressive. When compared with a traditional referral 
pathway, STTP saved on average 16 days from referral to 
diagnosis. This was achieved without a corresponding 
increase in diagnostic test requests suggesting that GPs can 
appropriately identify at risk patients in the community.
Although the effect on time to diagnosis was our 
primary outcome, there will be hidden benefits that were 
not captured. A difference of 16 days between the time 
taken from referral to diagnosis may result in improved 
health outcomes in patients without cancer too, partic-
ularly with a reduction in stress and concern as regards 
potential diagnoses. In patients without cancer, it will also 
allow the treating clinician to move onto other potential 
Table 2 Mean number of days (and 95% CI) for each step 
in referral pathway by group
Days; Mean (95% CI)
Measurement
STTP
Traditional 
pathway
Control 
Trusts
(n = 340) (n = 495) (n = 566) 
Referral to first 
seen
9.03 9.01 8.79
(8.64 to 9.42) (8.67 to 9.35) (8.11 to 9.48)
P<0.731
Referral to 
diagnosis
18 34 26
(17-20) (32-36) (24-29)
P<0.001
Diagnosis to 
treatment
31 24 32
(27-35) (21-27) (30-34)
P<0.001
Overall referral 
to treatment
46 53 58
(42-50) (49-58) (55-62) 
P<0.008 
STTP, straight to test pathway. 
Figure 1 Days from referral to diagnosis. Shows the length 
of time patients waited between referral and diagnosis 
in blocks of 10 days by STT, traditional and control 
pathway. STT, straight to test. 
Figure 2 Days from referral to treatment. Shows the length 
of time patients waited between referral and treatment 
in blocks of 10 days by STT, traditional and control 
pathway. STT, straight to test. 
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causes of the presenting symptoms and hypothetically 
result in earlier diagnosis.
There are caveats. Although the STTP had a shorter 
time from referral to treatment, the time from diagnosis to 
treatment was longer when compared with the traditional 
pathway. This may be due to case mix, with treatment deci-
sion potentially being quicker in patients who required 
best supportive care; however, the time from diagnosis to 
treatment in STTP was the same when compared with the 
control trusts.
Larger studies are needed to assess whether this reduc-
tion of 1 week results in an improvement in cancer survival. 
Like all pragmatic studies of health interventions, our 
study also has weaknesses. The introduction of STTP may 
have highlighted UGI cancer as a potential diagnosis to 
GPs participating in the scheme, although the fact that 
requested endoscopies did not increase (except in Derby 
which reflects a planned expansion in their service) and 
was similar to national figures, suggests this was not a major 
factor. UGI cancer may have been identified incidentally on 
endoscopies requested for non-cancer related indications 
(such as gastro-oesophageal reflux). These data were not 
captured. We also did not collect survival data as this was 
outside the funding scope of our project.
Our data showed that there was no increase in 
requested endoscopies; however, it is possible that 
the STTP may result in increased requested refer-
rals, leading to increasing pressure on the diagnostic 
pathway. Using the NICE referral criteria should miti-
gate this risk.
Overall a simple change in the way diagnostic tests 
are requested in UGI cancer results in a significant 
reduction in the time taken from referral to diagnosis. 
This is likely to have several health-related benefits and 
was achieved without an increase in the number of 
tests requested. This simple change is feasible, scalable 
and cost neutral. Larger studies are required to assess 
impact on cancer survival but given the simplicity of the 
intervention we suggest this should be copied across the 
UK.
Contributors JAJ gathered and analysed the data, analysis and co-wrote the first 
draft. He is also guarantor for the paper. JC was co-clinical lead and helped design 
the project. GH provided analytical support for the results section. PL was the co-
clinical lead and helped design and run the project. LB provided regional support. 
JH provided further analytical support for the results section. DES supported the 
analysis and co-wrote the first draft.
Funding This study was part of the Accelerate Communicate Evaluate (ACE) 
programme which was funded by Cancer Research UK. 
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
references
 1. The Institute for Health Metrics and Evaluation (IHME). Oesophageal 
cancer deaths by nation and region. 2013. www. healthdata. org/
 2. Office for National Statistics. One-year survival (%) for men and women 
diagnosed with a common cancer, diagnosed between 2009 and 2013 
and followed up to 2014. www. ons. gov. uk/ peop lepo pula tion andc 
ommunity/ healthandsocialcare/ cond itio nsan ddis eases/ bulletins/ canc 
ersu rviv alin engl anda dult sdia gnosed/ 2009 to20 13fo llow edup to2014
 3. National Cancer Registration & Analysis Service, Public Health England. 
Number of new cases of oesophageal and gastric cancers. 2014. www. 
cancerstats. nhs. uk
 4. National Cancer Registration & Analysis Service, Public Health England. 
Number of deaths due to oesophageal and gastric cancers. 2014. 
www. cancerstats. nhs. uk
 5. National Cancer Registration & Analysis Service, Public Health England. 
Crude incidence rate per 100,000 population of oesophageal and 
gastric cancers. 2014. www. cancerstats. nhs. uk
 6. World Health Organization. Early detection of cancer. www. who. int/ 
cancer/ detection/ en/
 7. International Cancer Benchmarking Partnership (ICBP). The role of 
primary care physicians in diagnosing cancer. www. cancerresearchuk. 
org/ health- professional/ data- and- statistics/ international- cancer- 
benchmarking- partnership- icbp/ icbp- findings# ICBP_ findings2
 8. Cancer Research UK. Improving diagnostic pathways for patients with 
suspected colorectal cancer. http://www. cancerresearchuk. org/ sites/ 
default/ files/ ace_-_ improving_ diagnostic_ pathways_ for_ patients_ with_ 
suspected_ colorectal_ cancer_-_ final_ report_ v1. 0_ 270617. pdf
 9. Department of Health. Direct Access to Diagnostic Tests for Cancer. 
Best Practice Referral Pathways for General Practitioners. https://www. 
gov. uk/ government/ uploads/ system/ uploads/ attachment_ data/ file/ 
216503/ dh_ 133511. pdf
 10. NHS Digital. Cancer Outcomes and Services Data Dictionary. www. 
datadictionary. nhs. uk
Table 3 Number of endoscopies performed by year, Trust and pathway
Endoscopies performed. Diagnostic imaging dataset 2013/14 2014/15 2015/16
Increase in endoscopies 
2013/2014 to 2015/2016 (%)
Non-STT 590 640 595 5 (1)
Northampton General Hospital NHS Trust 175 185 180 5 (3)
United Lincolnshire Hospitals NHS Trust 415 455 415 0 (0)
STT 2125 2335 2175 50 (2)
Derby Teaching Hospitals NHS Foundation Trust 235 425 515 280 (119)
Nottingham University Hospitals NHS Trust 780 740 435 −345 (−44)
University Hospitals of Leicester NHS Trust 1110 1170 1225 115 (10)
Total 2715 2975 2770 55 (2)
England 55 345 57 760 57 590 2245 (4)
STT, straight to test. 
 o
n
 10 August 2018 by guest. Protected by copyright.
http://bmjopenquality.bmj.com/
BM
J O
pen Qual: first published as 10.1136/bmjoq-2018-000328 on 21 July 2018. Downloaded from 
